Phase 1, First-in-Human Study of Futibatinib, a Highly...

  • Main
  • 2020 / 7
  • Phase 1, First-in-Human Study of Futibatinib, a Highly...
Annals of Oncology 2020 / 7

Phase 1, First-in-Human Study of Futibatinib, a Highly Selective, Irreversible FGFR1–4 Inhibitor in Patients with Advanced Solid Tumors

Bahleda, R., Meric-Bernstam, F., Goyal, L., Tran, B., He, Y., Yamamiya, I., Benhadji, K.A., Matos, I., Arkenau, H.-T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.06.018
Date:
July, 2020
File:
PDF, 891 KB
2020
Conversion to is in progress
Conversion to is failed